Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
Regulation Of cAMP-dependent Protein Kinase Activity (GO:2000479),3/13,1.7405573905994477e-7,6.057139719286078e-5,0,0,399.44,6216.840321302074,PRKAR2B;PRKAR2A;ADRB2
Positive Regulation Of Adenylate Cyclase Activity (GO:0045762),3/26,1.570838341380847e-6,2.733258714002674e-4,0,0,173.55652173913043,2319.392192773854,CACNA1C;ADRB2;RAF1
Negative Regulation Of cAMP-dependent Protein Kinase Activity (GO:2000480),2/7,1.602207143126473e-5,0.0018585602860267088,0,0,499.425,5514.4227735186505,PRKAR2B;PRKAR2A
Negative Regulation Of Protein Binding (GO:0032091),3/71,3.3668850292685725e-5,0.002385774835245404,0,0,58.57058823529412,603.2148259168996,CDKN1A;ADRB2;AURKA
Positive Regulation Of Protein Depolymerization (GO:1901881),2/10,3.427837406961788e-5,0.002385774835245404,0,0,312.09375,3208.634562990342,PLEK;STMN2
Negative Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071901),3/80,4.8154409077799535e-5,0.002792955726512373,0,0,51.701298701298704,513.9676695829695,CDKN1A;PRKAR2B;PRKAR2A
Positive Regulation Of Cell Activation (GO:0050867),2/15,7.977048122143578e-5,0.003610168199004239,0,0,192.0096153846154,1811.8712842401887,PLEK;RPS6KA1
Positive Regulation Of Supramolecular Fiber Organization (GO:1902905),3/96,8.299237239090204e-5,0.003610168199004239,0,0,42.77204301075269,401.91870215095247,VASP;PLEK;STMN2
Microtubule Depolymerization (GO:0007019),2/17,1.0321185160705684e-4,0.003990858262139531,0,0,166.39166666666668,1527.2636618368022,STMN2;KIF2C
Regulation Of Cell Cycle G2/M Phase Transition (GO:1902749),2/18,1.160515439074858e-4,0.004038593727980506,0,0,155.984375,1413.4486893926328,CDKN1A;AURKA
Negative Regulation Of Phosphate Metabolic Process (GO:0045936),2/20,1.4396293387323563e-4,0.0040992241248211155,0,0,138.63888888888889,1226.393330101256,CDKN1A;PLEK
Activation Of Adenylate Cyclase Activity (GO:0007190),2/20,1.4396293387323563e-4,0.0040992241248211155,0,0,138.63888888888889,1226.393330101256,ADRB2;RAF1
Regulation Of Protein Binding (GO:0043393),3/118,1.5313193569734053e-4,0.0040992241248211155,0,0,34.55130434782609,303.5059367755424,CDKN1A;AURKA;ADD2
Microtubule Polymerization Or Depolymerization (GO:0031109),2/27,2.649630840801269e-4,0.00658622523284887,0,0,99.785,821.821281893882,STMN2;KIF2C
Protein Depolymerization (GO:0051261),2/28,2.851929338387316e-4,0.006616476065058573,0,0,95.9423076923077,783.1141815068878,STMN2;KIF2C
Phosphorylation (GO:0016310),4/429,5.031039254623827e-4,0.010942510378806823,0,0,13.147563025210085,99.85197831696028,BCKDK;PRKCB;RPS6KA1;AURKA
Negative Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043154),2/49,8.773987974909651e-4,0.01727709414482819,0,0,53.0186170212766,373.1741306231756,RPS6KA1;RAF1
Protein Phosphorylation (GO:0006468),4/500,8.936428005945616e-4,0.01727709414482819,0,0,11.224654377880183,78.7993682152863,BCKDK;PRKCB;RPS6KA1;AURKA
Negative Regulation Of Cysteine-Type Endopeptidase Activity (GO:2000117),2/53,0.0010259208734402544,0.01879055073458992,0,0,48.85049019607843,336.19711708556474,RPS6KA1;RAF1
Monoatomic Cation Transmembrane Transport (GO:0098655),3/281,0.0019149945955117265,0.032709919246268426,0,0,14.175539568345323,88.71110042385895,KCNA1;KCNA3;CACNA1C
Inorganic Cation Transmembrane Transport (GO:0098662),3/284,0.001973874437274819,0.032709919246268426,0,0,14.022064056939502,87.32600685960846,KCNA1;KCNA3;CACNA1C
Positive Regulation Of Cytoskeleton Organization (GO:0051495),2/79,0.0022622747962299803,0.03578507404945605,0,0,32.313311688311686,196.83280353584135,VASP;PLEK
Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043281),2/84,0.002552851320063413,0.03578732615990515,0,0,30.335365853658537,181.11864810557336,RPS6KA1;RAF1
Supramolecular Fiber Organization (GO:0097435),3/316,0.002673439640569323,0.03578732615990515,0,0,12.568051118210862,74.4580285816208,MARCKS;STMN2;KIF2C
Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901990),2/86,0.0026737657475791204,0.03578732615990515,0,0,29.610119047619047,175.4182632174737,CDKN1A;AURKA
Negative Regulation Of Binding (GO:0051100),2/86,0.0026737657475791204,0.03578732615990515,0,0,29.610119047619047,175.4182632174737,CDKN1A;AURKA
Protein Modification Process (GO:0036211),4/711,0.003254284016859849,0.04194410510619361,0,0,7.789452414629218,44.61629305451239,BCKDK;PRKCB;RPS6KA1;AURKA
Mitotic Cell Cycle Phase Transition (GO:0044772),2/111,0.0044070373895657615,0.05211059541735844,0,0,22.790137614678898,123.6263004577948,CDKN1A;AURKA
Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071900),2/112,0.00448478018606296,0.05211059541735844,0,0,22.581818181818186,122.10137669299964,CDKN1A;ADRB2
Cellular Response To Magnesium Ion (GO:0071286),1/5,0.0044922927083929694,0.05211059541735844,0,0,293.79411764705884,1588.072397289777,KCNA1
Potassium Ion Transport (GO:0006813),2/122,0.0052970811067221055,0.05344054297620632,0,0,20.689583333333335,108.42581685908868,KCNA1;KCNA3
Positive Regulation Of B Cell Receptor Signaling Pathway (GO:0050861),1/6,0.0053884659389882355,0.05344054297620632,0,0,235.0235294117647,1227.644124299904,PRKCB
Mitotic Nuclear Membrane Disassembly (GO:0007077),1/6,0.0053884659389882355,0.05344054297620632,0,0,235.0235294117647,1227.644124299904,PRKCB
Regulation Of Inositol Phosphate Biosynthetic Process (GO:0010919),1/6,0.0053884659389882355,0.05344054297620632,0,0,235.0235294117647,1227.644124299904,PLEK
Detection Of Stimulus Involved In Sensory Perception Of Pain (GO:0062149),1/6,0.0053884659389882355,0.05344054297620632,0,0,235.0235294117647,1227.644124299904,KCNA1
Regulation Of Cell Cycle Process (GO:0010564),2/130,0.00599208526644116,0.05344054297620632,0,0,19.388671875,99.21795698165909,KIF2C;AURKA
Plasma Membrane Bounded Cell Projection Organization (GO:0120036),2/132,0.006172038024067215,0.05344054297620632,0,0,19.088461538461537,97.11686557699232,PLEK;STMN2
Circulatory System Development (GO:0072359),2/132,0.006172038024067215,0.05344054297620632,0,0,19.088461538461537,97.11686557699232,CDKN1A;CACNA1C
Stress-Induced Premature Senescence (GO:0090400),1/7,0.006283877774032595,0.05344054297620632,0,0,195.84313725490196,992.8792720611536,CDKN1A
Regulation Of DNA-templated Transcription In Response To Stress (GO:0043620),1/7,0.006283877774032595,0.05344054297620632,0,0,195.84313725490196,992.8792720611536,RPS6KA1
Negative Regulation Of Cellular Biosynthetic Process (GO:0031327),2/137,0.006632680432496716,0.05344054297620632,0,0,18.376851851851853,92.17362609399046,CDKN1A;PLEK
Potassium Ion Transmembrane Transport (GO:0071805),2/137,0.006632680432496716,0.05344054297620632,0,0,18.376851851851853,92.17362609399046,KCNA1;KCNA3
Negative Regulation Of Systemic Arterial Blood Pressure (GO:0003085),1/8,0.007178528720410204,0.05344054297620632,0,0,167.85714285714286,828.6537822644398,ADRB2
Response To Magnesium Ion (GO:0032026),1/8,0.007178528720410204,0.05344054297620632,0,0,167.85714285714286,828.6537822644398,KCNA1
Neuronal Action Potential (GO:0019228),1/8,0.007178528720410204,0.05344054297620632,0,0,167.85714285714286,828.6537822644398,KCNA1
Nuclear Membrane Disassembly (GO:0051081),1/8,0.007178528720410204,0.05344054297620632,0,0,167.85714285714286,828.6537822644398,PRKCB
Positive Regulation Of Protein Kinase Activity (GO:0045860),2/145,0.007401409374967147,0.05344054297620632,0,0,17.341783216783217,85.08025975281727,CDKN1A;ADRB2
Calcium Ion Transport Into Cytosol (GO:0060402),1/9,0.008072419310050151,0.05344054297620632,0,0,146.86764705882354,707.7995527019895,CACNA1C
Positive Regulation Of Platelet Activation (GO:0010572),1/9,0.008072419310050151,0.05344054297620632,0,0,146.86764705882354,707.7995527019895,PLEK
Positive Regulation Of Protein Kinase A Signaling (GO:0010739),1/9,0.008072419310050151,0.05344054297620632,0,0,146.86764705882354,707.7995527019895,ADRB2
Positive Regulation Of Vascular Endothelial Growth Factor Receptor Signaling Pathway (GO:0030949),1/9,0.008072419310050151,0.05344054297620632,0,0,146.86764705882354,707.7995527019895,PRKCB
Peptidyl-Serine Phosphorylation (GO:0018105),2/158,0.008732577066799934,0.05344054297620632,0,0,15.886217948717947,75.3117101227541,PRKCB;AURKA
Positive Regulation Of Integrin Activation (GO:0033625),1/10,0.008965550093347357,0.05344054297620632,0,0,130.54248366013073,615.425022203049,PLEK
Protein Kinase C Signaling (GO:0070528),1/10,0.008965550093347357,0.05344054297620632,0,0,130.54248366013073,615.425022203049,PLEK
Positive Regulation Of Actin Filament Depolymerization (GO:0030836),1/10,0.008965550093347357,0.05344054297620632,0,0,130.54248366013073,615.425022203049,PLEK
Negative Regulation Of Transmembrane Transport (GO:0034763),1/10,0.008965550093347357,0.05344054297620632,0,0,130.54248366013073,615.425022203049,PRKCB
Peptidyl-Serine Modification (GO:0018209),2/166,0.009601370877517652,0.05344054297620632,0,0,15.105182926829269,70.1764049009769,PRKCB;AURKA
Negative Regulation Of Glucose Transmembrane Transport (GO:0010829),1/11,0.009857921634816497,0.05344054297620632,0,0,117.48235294117649,542.7073703814344,PRKCB
Negative Regulation Of Microtubule Polymerization (GO:0031115),1/11,0.009857921634816497,0.05344054297620632,0,0,117.48235294117649,542.7073703814344,STMN2
Regulation Of Ventricular Cardiac Muscle Cell Action Potential (GO:0098911),1/11,0.009857921634816497,0.05344054297620632,0,0,117.48235294117649,542.7073703814344,CACNA1C
Regulation Of Actin Filament Depolymerization (GO:0030834),1/11,0.009857921634816497,0.05344054297620632,0,0,117.48235294117649,542.7073703814344,PLEK
Desensitization Of G Protein-Coupled Receptor Signaling Pathway (GO:0002029),1/11,0.009857921634816497,0.05344054297620632,0,0,117.48235294117649,542.7073703814344,ADRB2
Regulation Of Muscle System Process (GO:0090257),1/11,0.009857921634816497,0.05344054297620632,0,0,117.48235294117649,542.7073703814344,KCNA1
Lipoprotein Transport (GO:0042953),1/11,0.009857921634816497,0.05344054297620632,0,0,117.48235294117649,542.7073703814344,PRKCB
Metal Ion Transport (GO:0030001),2/171,0.010163275132191497,0.05344054297620632,0,0,14.654585798816568,67.24952102604539,KCNA1;KCNA3
Heart Development (GO:0007507),2/171,0.010163275132191497,0.05344054297620632,0,0,14.654585798816568,67.24952102604539,CDKN1A;CACNA1C
Negative Regulation Of Alcohol Biosynthetic Process (GO:1902931),1/12,0.010749534506708168,0.05344054297620632,0,0,106.79679144385028,484.0984098875249,PLEK
Atrial Cardiac Muscle Cell Action Potential (GO:0086014),1/12,0.010749534506708168,0.05344054297620632,0,0,106.79679144385028,484.0984098875249,CACNA1C
Attachment Of Mitotic Spindle Microtubules To Kinetochore (GO:0051315),1/12,0.010749534506708168,0.05344054297620632,0,0,106.79679144385028,484.0984098875249,KIF2C
Lipoprotein Localization (GO:0044872),1/12,0.010749534506708168,0.05344054297620632,0,0,106.79679144385028,484.0984098875249,PRKCB
Positive Regulation Of Intracellular Signal Transduction (GO:1902533),3/525,0.010940791135407423,0.05362528612847583,0,0,7.455938697318008,33.66548065284205,PRKCB;ADRB2;RAF1
Membrane Depolarization During Action Potential (GO:0086010),1/13,0.011640389286531057,0.05396215549523489,0,0,97.8921568627451,435.94063546940737,CACNA1C
Response To Nerve Growth Factor (GO:1990089),1/13,0.011640389286531057,0.05396215549523489,0,0,97.8921568627451,435.94063546940737,STMN2
Positive Regulation Of Cyclase Activity (GO:0031281),1/13,0.011640389286531057,0.05396215549523489,0,0,97.8921568627451,435.94063546940737,CACNA1C
Establishment Of Chromosome Localization (GO:0051303),1/14,0.01253048655713669,0.05396215549523489,0,0,90.3574660633484,395.7287161899813,KIF2C
Positive Regulation Of Lyase Activity (GO:0051349),1/14,0.01253048655713669,0.05396215549523489,0,0,90.3574660633484,395.7287161899813,CACNA1C
Regulation Of Integrin Activation (GO:0033623),1/14,0.01253048655713669,0.05396215549523489,0,0,90.3574660633484,395.7287161899813,PLEK
Detection Of Mechanical Stimulus Involved In Sensory Perception (GO:0050974),1/14,0.01253048655713669,0.05396215549523489,0,0,90.3574660633484,395.7287161899813,KCNA1
Regulation Of Cell Differentiation (GO:0045595),2/193,0.012804955398895276,0.05396215549523489,0,0,12.952225130890051,56.44480034874298,RPS6KA1;RAF1
Vasodilation (GO:0042311),1/15,0.01341982690512007,0.05396215549523489,0,0,83.89915966386555,361.6911269349327,ADRB2
Adenylate Cyclase-Activating Adrenergic Receptor Signaling Pathway (GO:0071880),1/15,0.01341982690512007,0.05396215549523489,0,0,83.89915966386555,361.6911269349327,ADRB2
Regulation Of Carbohydrate Metabolic Process (GO:0006109),1/15,0.01341982690512007,0.05396215549523489,0,0,83.89915966386555,361.6911269349327,BCKDK
Branched-Chain Amino Acid Metabolic Process (GO:0009081),1/15,0.01341982690512007,0.05396215549523489,0,0,83.89915966386555,361.6911269349327,BCKDK
Anterograde Trans-Synaptic Signaling (GO:0098916),2/199,0.013572377410395225,0.05396215549523489,0,0,12.553934010152284,53.978383873324965,KCNA1;RPS6KA1
Regulation Of MAPK Cascade (GO:0043408),2/204,0.01422697308896148,0.05396215549523489,0,0,12.240099009900993,52.052436030078844,ADRB2;RAF1
Regulation Of Protein Kinase A Signaling (GO:0010738),1/16,0.014308410919694987,0.05396215549523489,0,0,78.30196078431372,332.5412031884909,ADRB2
Cell Communication By Electrical Coupling Involved In Cardiac Conduction (GO:0086064),1/16,0.014308410919694987,0.05396215549523489,0,0,78.30196078431372,332.5412031884909,CACNA1C
Membrane Depolarization During Cardiac Muscle Cell Action Potential (GO:0086012),1/16,0.014308410919694987,0.05396215549523489,0,0,78.30196078431372,332.5412031884909,CACNA1C
Regulation Of B Cell Receptor Signaling Pathway (GO:0050855),1/16,0.014308410919694987,0.05396215549523489,0,0,78.30196078431372,332.5412031884909,PRKCB
Ruffle Organization (GO:0031529),1/16,0.014308410919694987,0.05396215549523489,0,0,78.30196078431372,332.5412031884909,PLEK
Regulation Of Cardiac Muscle Contraction By Regulation Of The Release Of Sequestered Calcium Ion (GO:0010881),1/16,0.014308410919694987,0.05396215549523489,0,0,78.30196078431372,332.5412031884909,CACNA1C
Nuclear Chromosome Segregation (GO:0098813),1/16,0.014308410919694987,0.05396215549523489,0,0,78.30196078431372,332.5412031884909,KIF2C
Carboxylic Acid Catabolic Process (GO:0046395),1/17,0.015196239191186836,0.05396215549523489,0,0,73.40441176470588,307.3227868353231,BCKDK
"DNA Damage Response, Signal Transduction By P53 Class Mediator Resulting In Cell Cycle Arrest (GO:0006977)",1/17,0.015196239191186836,0.05396215549523489,0,0,73.40441176470588,307.3227868353231,CDKN1A
Regulation Of Glucose Transmembrane Transport (GO:0010827),1/17,0.015196239191186836,0.05396215549523489,0,0,73.40441176470588,307.3227868353231,PRKCB
Negative Regulation Of Vascular Associated Smooth Muscle Cell Proliferation (GO:1904706),1/17,0.015196239191186836,0.05396215549523489,0,0,73.40441176470588,307.3227868353231,CDKN1A
Regulation Of Adenylate Cyclase Activity (GO:0045761),1/17,0.015196239191186836,0.05396215549523489,0,0,73.40441176470588,307.3227868353231,CACNA1C
Branched-Chain Amino Acid Catabolic Process (GO:0009083),1/17,0.015196239191186836,0.05396215549523489,0,0,73.40441176470588,307.3227868353231,BCKDK
Cardiac Muscle Cell Contraction (GO:0086003),1/18,0.0160833123117468,0.054339734800853266,0,0,69.08304498269896,285.3111137768628,CACNA1C
Actin Filament Capping (GO:0051693),1/18,0.0160833123117468,0.054339734800853266,0,0,69.08304498269896,285.3111137768628,ADD2
Adrenergic Receptor Signaling Pathway (GO:0071875),1/18,0.0160833123117468,0.054339734800853266,0,0,69.08304498269896,285.3111137768628,ADRB2
Neuromuscular Process (GO:0050905),1/18,0.0160833123117468,0.054339734800853266,0,0,69.08304498269896,285.3111137768628,KCNA1
Barbed-End Actin Filament Capping (GO:0051016),1/18,0.0160833123117468,0.054339734800853266,0,0,69.08304498269896,285.3111137768628,ADD2
Cortical Actin Cytoskeleton Organization (GO:0030866),1/19,0.016969630876880012,0.0559079074078329,0,0,65.24183006535948,265.9472259849427,PLEK
Negative Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0045736),1/19,0.016969630876880012,0.0559079074078329,0,0,65.24183006535948,265.9472259849427,CDKN1A
Regulation Of Cell Growth (GO:0001558),2/227,0.017411122035000618,0.0559079074078329,0,0,10.976111111111113,44.46034144089977,CDKN1A;RPS6KA1
Cell Projection Organization (GO:0030030),1/20,0.017855195476470426,0.0559079074078329,0,0,61.80495356037152,248.79341471282055,PLEK
Negative Regulation Of Microtubule Depolymerization (GO:0007026),1/20,0.017855195476470426,0.0559079074078329,0,0,61.80495356037152,248.79341471282055,STMN2
Positive Regulation Of Antigen Receptor-Mediated Signaling Pathway (GO:0050857),1/20,0.017855195476470426,0.0559079074078329,0,0,61.80495356037152,248.79341471282055,PRKCB
Regulation Of Cardiac Muscle Contraction By Calcium Ion Signaling (GO:0010882),1/20,0.017855195476470426,0.0559079074078329,0,0,61.80495356037152,248.79341471282055,CACNA1C
Negative Regulation Of Cyclin-Dependent Protein Kinase Activity (GO:1904030),1/20,0.017855195476470426,0.0559079074078329,0,0,61.80495356037152,248.79341471282055,CDKN1A
Negative Regulation Of Intracellular Signal Transduction (GO:1902532),2/231,0.01799334951056691,0.0559079074078329,0,0,10.782205240174672,43.320238107962304,PLEK;RPS6KA1
Positive Regulation Of Developmental Process (GO:0051094),2/233,0.018287570765843603,0.056319244482421,0,0,10.687770562770565,42.76747347574325,RPS6KA1;AURKA
Cellular Response To Nerve Growth Factor Stimulus (GO:1990090),1/21,0.01874000670829494,0.05720633626742666,0,0,58.71176470588235,233.50224496360525,STMN2
Regulation Of Release Of Sequestered Calcium Ion Into Cytosol By Sarcoplasmic Reticulum (GO:0010880),1/22,0.019624065171284413,0.057874361691584546,0,0,55.91316526610644,219.7945772360195,CACNA1C
Regulation Of Vascular Endothelial Growth Factor Receptor Signaling Pathway (GO:0030947),1/22,0.019624065171284413,0.057874361691584546,0,0,55.91316526610644,219.7945772360195,PRKCB
Positive Regulation Of Phosphatase Activity (GO:0010922),1/22,0.019624065171284413,0.057874361691584546,0,0,55.91316526610644,219.7945772360195,PLEK
Negative Regulation Of G Protein-Coupled Receptor Signaling Pathway (GO:0045744),1/22,0.019624065171284413,0.057874361691584546,0,0,55.91316526610644,219.7945772360195,PLEK
Regulation Of Centrosome Cycle (GO:0046605),1/23,0.02050737145707836,0.05947137722552725,0,0,53.36898395721925,207.44368622737056,AURKA
Negative Regulation Of Protein Depolymerization (GO:1901880),1/23,0.02050737145707836,0.05947137722552725,0,0,53.36898395721925,207.44368622737056,STMN2
Regulation Of Microtubule Depolymerization (GO:0031114),1/24,0.02138992615773652,0.06062656715554622,0,0,51.0460358056266,196.26359569838613,STMN2
Regulation Of Cell Cycle Phase Transition (GO:1901987),1/25,0.02227172987906945,0.06062656715554622,0,0,48.916666666666664,186.10038260880103,CDKN1A
Regulation Of Cell Size (GO:0008361),1/25,0.02227172987906945,0.06062656715554622,0,0,48.916666666666664,186.10038260880103,PLEK
Camera-Type Eye Development (GO:0043010),1/26,0.023152783214921657,0.06062656715554622,0,0,46.95764705882353,176.82560723797164,CACNA1C
Negative Regulation Of Insulin Receptor Signaling Pathway (GO:0046627),1/26,0.023152783214921657,0.06062656715554622,0,0,46.95764705882353,176.82560723797164,PRKCB
Positive Regulation Of Microtubule Polymerization Or Depolymerization (GO:0031112),1/26,0.023152783214921657,0.06062656715554622,0,0,46.95764705882353,176.82560723797164,STMN2
Mitotic G1 DNA Damage Checkpoint Signaling (GO:0031571),1/26,0.023152783214921657,0.06062656715554622,0,0,46.95764705882353,176.82560723797164,CDKN1A
Negative Regulation Of Protein Polymerization (GO:0032272),1/26,0.023152783214921657,0.06062656715554622,0,0,46.95764705882353,176.82560723797164,STMN2
Regulation Of Actin Filament Bundle Assembly (GO:0032231),1/26,0.023152783214921657,0.06062656715554622,0,0,46.95764705882353,176.82560723797164,PLEK
Regulation Of Cardiac Muscle Cell Contraction (GO:0086004),1/26,0.023152783214921657,0.06062656715554622,0,0,46.95764705882353,176.82560723797164,CACNA1C
Negative Regulation Of Signal Transduction (GO:0009968),2/267,0.023598706599198247,0.06062656715554622,0,0,9.300471698113208,34.84480662108599,PRKCB;PLEK
Positive Regulation Of Mitotic Cell Cycle (GO:0045931),1/27,0.02403308675659661,0.06062656715554622,0,0,45.14932126696833,168.33128827465845,AURKA
Cortical Cytoskeleton Organization (GO:0030865),1/27,0.02403308675659661,0.06062656715554622,0,0,45.14932126696833,168.33128827465845,PLEK
Regulation Of Microtubule Polymerization Or Depolymerization (GO:0031110),1/27,0.02403308675659661,0.06062656715554622,0,0,45.14932126696833,168.33128827465845,STMN2
Negative Regulation Of Cellular Response To Insulin Stimulus (GO:1900077),1/27,0.02403308675659661,0.06062656715554622,0,0,45.14932126696833,168.33128827465845,PRKCB
Chemical Synaptic Transmission (GO:0007268),2/273,0.024595085530588232,0.06062656715554622,0,0,9.09178966789668,33.686977550371914,KCNA1;RPS6KA1
Regulation Of Chromosome Segregation (GO:0051983),1/28,0.0249126411012733,0.06062656715554622,0,0,43.474945533769066,160.52601632867996,KIF2C
Regulation Of Glucose Metabolic Process (GO:0010906),1/28,0.0249126411012733,0.06062656715554622,0,0,43.474945533769066,160.52601632867996,BCKDK
Hematopoietic Progenitor Cell Differentiation (GO:0002244),1/28,0.0249126411012733,0.06062656715554622,0,0,43.474945533769066,160.52601632867996,PLEK
Regulation Of Cardiac Muscle Cell Action Potential (GO:0098901),1/28,0.0249126411012733,0.06062656715554622,0,0,43.474945533769066,160.52601632867996,CACNA1C
Regulation Of Platelet Activation (GO:0010543),1/28,0.0249126411012733,0.06062656715554622,0,0,43.474945533769066,160.52601632867996,PLEK
Primary Neural Tube Formation (GO:0014020),1/28,0.0249126411012733,0.06062656715554622,0,0,43.474945533769066,160.52601632867996,VASP
Positive Regulation Of Fibroblast Proliferation (GO:0048146),1/28,0.0249126411012733,0.06062656715554622,0,0,43.474945533769066,160.52601632867996,CDKN1A
Cardiac Muscle Cell Action Potential (GO:0086001),1/29,0.02579144685281,0.06147550345738275,0,0,41.92016806722689,153.33191684558912,CACNA1C
Tube Closure (GO:0060606),1/29,0.02579144685281,0.06147550345738275,0,0,41.92016806722689,153.33191684558912,VASP
Regulation Of Muscle Contraction (GO:0006937),1/29,0.02579144685281,0.06147550345738275,0,0,41.92016806722689,153.33191684558912,KCNA1
Cardiac Muscle Cell Action Potential Involved In Contraction (GO:0086002),1/30,0.02666950460061794,0.06187325067343362,0,0,40.47261663286004,146.68225415832842,CACNA1C
Mitotic G2 DNA Damage Checkpoint Signaling (GO:0007095),1/30,0.02666950460061794,0.06187325067343362,0,0,40.47261663286004,146.68225415832842,CDKN1A
Negative Regulation Of Carbohydrate Metabolic Process (GO:0045912),1/30,0.02666950460061794,0.06187325067343362,0,0,40.47261663286004,146.68225415832842,PLEK
Regulation Of Calcium-Mediated Signaling (GO:0050848),1/30,0.02666950460061794,0.06187325067343362,0,0,40.47261663286004,146.68225415832842,PLEK
Negative Regulation Of Developmental Growth (GO:0048640),1/31,0.02754681494066949,0.06265550064936588,0,0,39.12156862745098,140.51952455455398,CDKN1A
Negative Regulation Of Microtubule Polymerization Or Depolymerization (GO:0031111),1/31,0.02754681494066949,0.06265550064936588,0,0,39.12156862745098,140.51952455455398,STMN2
Negative Regulation Of DNA Biosynthetic Process (GO:2000279),1/31,0.02754681494066949,0.06265550064936588,0,0,39.12156862745098,140.51952455455398,CDKN1A
Regulation Of Transmembrane Transport (GO:0034762),1/32,0.028423378470110255,0.06340599812563057,0,0,37.85768500948767,134.79392621731594,PRKCB
Negative Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000134),1/32,0.028423378470110255,0.06340599812563057,0,0,37.85768500948767,134.79392621731594,CDKN1A
Neural Tube Closure (GO:0001843),1/32,0.028423378470110255,0.06340599812563057,0,0,37.85768500948767,134.79392621731594,VASP
Positive Regulation Of Ion Transmembrane Transporter Activity (GO:0032414),1/33,0.02929919579032357,0.06369020126281338,0,0,36.67279411764706,129.4621221594897,ADRB2
Actin Filament Bundle Assembly (GO:0051017),1/33,0.02929919579032357,0.06369020126281338,0,0,36.67279411764706,129.4621221594897,ADD2
Actin Filament Bundle Organization (GO:0061572),1/33,0.02929919579032357,0.06369020126281338,0,0,36.67279411764706,129.4621221594897,ADD2
Negative Regulation Of Small Molecule Metabolic Process (GO:0062014),1/33,0.02929919579032357,0.06369020126281338,0,0,36.67279411764706,129.4621221594897,BCKDK
Cellular Response To Amyloid-Beta (GO:1904646),1/34,0.030174267482518016,0.06369020126281338,0,0,35.559714795008915,124.48623298308226,ADRB2
Regulation Of DNA Biosynthetic Process (GO:2000278),1/34,0.030174267482518016,0.06369020126281338,0,0,35.559714795008915,124.48623298308226,CDKN1A
Embryonic Limb Morphogenesis (GO:0030326),1/34,0.030174267482518016,0.06369020126281338,0,0,35.559714795008915,124.48623298308226,CACNA1C
Positive Regulation Of Mitotic Nuclear Division (GO:0045840),1/35,0.031048594155870846,0.06369020126281338,0,0,34.5121107266436,119.83301120641356,AURKA
Platelet Aggregation (GO:0070527),1/35,0.031048594155870846,0.06369020126281338,0,0,34.5121107266436,119.83301120641356,PLEK
Action Potential (GO:0001508),1/35,0.031048594155870846,0.06369020126281338,0,0,34.5121107266436,119.83301120641356,KCNA1
Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010389),1/35,0.031048594155870846,0.06369020126281338,0,0,34.5121107266436,119.83301120641356,CDKN1A
Negative Regulation Of Cell Cycle G1/S Phase Transition (GO:1902807),1/35,0.031048594155870846,0.06369020126281338,0,0,34.5121107266436,119.83301120641356,CDKN1A
Liver Development (GO:0001889),1/35,0.031048594155870846,0.06369020126281338,0,0,34.5121107266436,119.83301120641356,AURKA
Positive Regulation Of MAPK Cascade (GO:0043410),2/310,0.031113029352523785,0.06369020126281338,0,0,7.984577922077922,27.70751218469436,ADRB2;RAF1
"DNA Damage Response, Signal Transduction By P53 Class Mediator (GO:0030330)",1/36,0.03192217639649051,0.06458672898824824,0,0,33.52436974789916,115.4731604004656,CDKN1A
Positive Regulation Of Signaling Receptor Activity (GO:2000273),1/36,0.03192217639649051,0.06458672898824824,0,0,33.52436974789916,115.4731604004656,ADRB2
Calcium Ion Import Across Plasma Membrane (GO:0098703),1/37,0.0327950148043916,0.06521522943959016,0,0,32.591503267973856,111.38077026649428,CACNA1C
Regulation Of Vascular Associated Smooth Muscle Cell Proliferation (GO:1904705),1/37,0.0327950148043916,0.06521522943959016,0,0,32.591503267973856,111.38077026649428,CDKN1A
Negative Regulation Of Smooth Muscle Cell Proliferation (GO:0048662),1/37,0.0327950148043916,0.06521522943959016,0,0,32.591503267973856,111.38077026649428,CDKN1A
G2/M Transition Of Mitotic Cell Cycle (GO:0000086),1/38,0.03366710996592093,0.06619296196689539,0,0,31.70906200317965,107.5328454820737,AURKA
Amino Acid Catabolic Process (GO:0009063),1/38,0.03366710996592093,0.06619296196689539,0,0,31.70906200317965,107.5328454820737,BCKDK
Protein-Containing Complex Assembly (GO:0065003),2/328,0.03450762582728679,0.06733528625715729,0,0,7.53680981595092,25.373235060695535,ADRB2;ADD2
Cell Cycle G2/M Phase Transition (GO:0044839),1/40,0.03540907294557409,0.06733528625715729,0,0,30.07993966817496,100.49067723322013,AURKA
Regulation Of Small Molecule Metabolic Process (GO:0062012),1/40,0.03540907294557409,0.06733528625715729,0,0,30.07993966817496,100.49067723322013,BCKDK
Negative Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901991),1/40,0.03540907294557409,0.06733528625715729,0,0,30.07993966817496,100.49067723322013,CDKN1A
Regulation Of Microtubule Cytoskeleton Organization (GO:0070507),1/40,0.03540907294557409,0.06733528625715729,0,0,30.07993966817496,100.49067723322013,STMN2
Regulation Of Microtubule Polymerization (GO:0031113),1/40,0.03540907294557409,0.06733528625715729,0,0,30.07993966817496,100.49067723322013,STMN2
Regulation Of Heart Rate By Cardiac Conduction (GO:0086091),1/41,0.036278941946159535,0.06751375292654288,0,0,29.326470588235296,97.26176223664352,CACNA1C
Positive Regulation Of Actin Filament Polymerization (GO:0030838),1/41,0.036278941946159535,0.06751375292654288,0,0,29.326470588235296,97.26176223664352,VASP
Response To Amino Acid Starvation (GO:1990928),1/41,0.036278941946159535,0.06751375292654288,0,0,29.326470588235296,97.26176223664352,CDKN1A
Regulation Of Microtubule-Based Process (GO:0032886),1/41,0.036278941946159535,0.06751375292654288,0,0,29.326470588235296,97.26176223664352,AURKA
Cellular Response To Amino Acid Starvation (GO:0034198),1/42,0.03714807008538698,0.068763448881461,0,0,28.609756097560975,94.20744821276294,CDKN1A
Response To Amyloid-Beta (GO:1904645),1/43,0.038016457940095186,0.06999855747700065,0,0,27.92717086834734,91.3144790197023,ADRB2
Regulation Of Insulin Receptor Signaling Pathway (GO:0046626),1/44,0.038884106119434915,0.07121931015559657,0,0,27.276333789329687,88.57088446864675,PRKCB
B Cell Receptor Signaling Pathway (GO:0050853),1/46,0.04061718578452446,0.07211622782150261,0,0,26.061437908496732,83.48948444789488,PRKCB
Cardiac Conduction (GO:0061337),1/46,0.04061718578452446,0.07211622782150261,0,0,26.061437908496732,83.48948444789488,CACNA1C
Regulation Of Fibroblast Proliferation (GO:0048145),1/46,0.04061718578452446,0.07211622782150261,0,0,26.061437908496732,83.48948444789488,CDKN1A
Mitotic G2/M Transition Checkpoint (GO:0044818),1/46,0.04061718578452446,0.07211622782150261,0,0,26.061437908496732,83.48948444789488,CDKN1A
Homotypic Cell-Cell Adhesion (GO:0034109),1/46,0.04061718578452446,0.07211622782150261,0,0,26.061437908496732,83.48948444789488,PLEK
Negative Regulation Of Cellular Metabolic Process (GO:0031324),1/46,0.04061718578452446,0.07211622782150261,0,0,26.061437908496732,83.48948444789488,BCKDK
Regulation Of Signal Transduction By P53 Class Mediator (GO:1901796),1/47,0.0414826184608072,0.07327894022518226,0,0,25.493606138107417,81.1329113370927,AURKA
Cellular Response To Radiation (GO:0071478),1/48,0.042347313814152854,0.07368432603662596,0,0,24.94993742177722,78.88796682594588,CDKN1A
Positive Regulation Of Reactive Oxygen Species Metabolic Process (GO:2000379),1/48,0.042347313814152854,0.07368432603662596,0,0,24.94993742177722,78.88796682594588,CDKN1A
Post-Translational Protein Modification (GO:0043687),1/48,0.042347313814152854,0.07368432603662596,0,0,24.94993742177722,78.88796682594588,PRKCB
Negative Regulation Of DNA Metabolic Process (GO:0051053),1/49,0.04321127244441888,0.07481354632168044,0,0,24.42892156862745,76.74721626832032,CDKN1A
Mitotic Metaphase Plate Congression (GO:0007080),1/50,0.04407449493169267,0.07518302736141616,0,0,23.92917166866747,74.70385911458476,KIF2C
Negative Regulation Of Cell Projection Organization (GO:0031345),1/50,0.04407449493169267,0.07518302736141616,0,0,23.92917166866747,74.70385911458476,STMN2
Positive Regulation Of Protein Phosphorylation (GO:0001934),2/377,0.044442323544709256,0.07518302736141616,0,0,6.535666666666667,20.34921011361273,CDKN1A;RAF1
Negative Regulation Of Cell Population Proliferation (GO:0008285),2/379,0.04486842078334325,0.07518302736141616,0,0,6.5003315649867375,20.177166042152088,CDKN1A;RAF1
Metaphase Plate Congression (GO:0051310),1/51,0.044936981871191266,0.07518302736141616,0,0,23.44941176470588,72.75166337328601,KIF2C
Regulated Exocytosis (GO:0045055),1/51,0.044936981871191266,0.07518302736141616,0,0,23.44941176470588,72.75166337328601,PLEK
Positive Regulation Of Actin Filament Bundle Assembly (GO:0032233),1/51,0.044936981871191266,0.07518302736141616,0,0,23.44941176470588,72.75166337328601,PLEK
Negative Regulation Of Programmed Cell Death (GO:0043069),2/381,0.04529607717964973,0.07542121941874692,0,0,6.4653693931398415,20.007310883978892,RPS6KA1;RAF1
Cell Cycle G1/S Phase Transition (GO:0044843),1/52,0.04579873384946774,0.07553535251002262,0,0,22.988465974625143,70.88490801561363,CDKN1A
Cellular Response To Ionizing Radiation (GO:0071479),1/52,0.04579873384946774,0.07553535251002262,0,0,22.988465974625143,70.88490801561363,CDKN1A
Regulation Of Cyclin-Dependent Protein Kinase Activity (GO:1904029),1/53,0.04665975146146969,0.07623283337366879,0,0,22.54524886877828,69.09833217880467,CDKN1A
Actin Cytoskeleton Reorganization (GO:0031532),1/53,0.04665975146146969,0.07623283337366879,0,0,22.54524886877828,69.09833217880467,PLEK
Organelle Disassembly (GO:1903008),1/54,0.04752003528742647,0.07656005685196486,0,0,22.11875693673696,67.38709029166962,AURKA
Negative Regulation Of Neuron Projection Development (GO:0010977),1/54,0.04752003528742647,0.07656005685196486,0,0,22.11875693673696,67.38709029166962,STMN2
Negative Regulation Of TOR Signaling (GO:0032007),1/54,0.04752003528742647,0.07656005685196486,0,0,22.11875693673696,67.38709029166962,RPS6KA1
Regulation Of Reactive Oxygen Species Metabolic Process (GO:2000377),1/56,0.0492384039303871,0.07753377632477244,0,0,21.31229946524064,64.173068346434,CDKN1A
Mitotic DNA Damage Checkpoint Signaling (GO:0044773),1/56,0.0492384039303871,0.07753377632477244,0,0,21.31229946524064,64.173068346434,CDKN1A
Cellular Response To Peptide (GO:1901653),1/56,0.0492384039303871,0.07753377632477244,0,0,21.31229946524064,64.173068346434,ADRB2
Regulation Of Mitotic Nuclear Division (GO:0007088),1/56,0.0492384039303871,0.07753377632477244,0,0,21.31229946524064,64.173068346434,AURKA
Positive Regulation Of Cellular Metabolic Process (GO:0031325),1/56,0.0492384039303871,0.07753377632477244,0,0,21.31229946524064,64.173068346434,CDKN1A
Eye Development (GO:0001654),1/58,0.0509538444953197,0.0795154165218442,0,0,20.562435500515996,61.21097903869968,CACNA1C
Positive Regulation Of Mitochondrion Organization (GO:0010822),1/58,0.0509538444953197,0.0795154165218442,0,0,20.562435500515996,61.21097903869968,AURKA
Negative Regulation Of Protein-Containing Complex Assembly (GO:0031333),1/59,0.05181046820697307,0.08013352416011835,0,0,20.20689655172414,59.815708753826954,RAF1
Positive Regulation Of Protein Binding (GO:0032092),1/59,0.05181046820697307,0.08013352416011835,0,0,20.20689655172414,59.815708753826954,ADD2
Glycerophospholipid Metabolic Process (GO:0006650),1/62,0.05437596012922433,0.08372935453526577,0,0,19.210221793635487,55.93696029523851,PLEK
G1/S Transition Of Mitotic Cell Cycle (GO:0000082),1/63,0.05522966630423428,0.08429791172751548,0,0,18.89943074003795,54.73757147758474,CDKN1A
Phosphatidylinositol Metabolic Process (GO:0046488),1/63,0.05522966630423428,0.08429791172751548,0,0,18.89943074003795,54.73757147758474,PLEK
Positive Regulation Of Cell Cycle (GO:0045787),1/65,0.0569348954637786,0.08652115118513079,0,0,18.30698529411765,52.46501611587855,AURKA
Regulation Of Heart Contraction (GO:0008016),1/69,0.06033663736484967,0.09129195566507688,0,0,17.226643598615915,48.3692416453001,CACNA1C
Regulation Of G Protein-Coupled Receptor Signaling Pathway (GO:0008277),1/70,0.06118526031669336,0.0913839939493961,0,0,16.97612958226769,47.42874202866335,PLEK
Positive Regulation Of Protein Polymerization (GO:0032273),1/70,0.06118526031669336,0.0913839939493961,0,0,16.97612958226769,47.42874202866335,VASP
Regulation Of Actin Filament Polymerization (GO:0030833),1/70,0.06118526031669336,0.0913839939493961,0,0,16.97612958226769,47.42874202866335,VASP
Negative Regulation Of Supramolecular Fiber Organization (GO:1902904),1/71,0.06203315941729082,0.09225444221032994,0,0,16.7327731092437,46.51855173584374,STMN2
Response To Ionizing Radiation (GO:0010212),1/72,0.0628803352568931,0.09311641135914382,0,0,16.496271748135875,45.63729539644487,CDKN1A
Regulation Of Rho Protein Signal Transduction (GO:0035023),1/73,0.06372678840915502,0.0939700100270591,0,0,16.266339869281047,44.783677915691136,RAF1
Regulation Of Cell Cycle G1/S Phase Transition (GO:1902806),1/74,0.06457251945477355,0.09481534502219914,0,0,16.042707493956488,43.95647876269956,CDKN1A
Negative Regulation Of Phosphorylation (GO:0042326),1/75,0.06541752897671287,0.09565252136090788,0,0,15.825119236883944,43.154546742931096,CDKN1A
Regulation Of Ras Protein Signal Transduction (GO:0046578),1/76,0.06626181755179136,0.09648164229298492,0,0,15.613333333333332,42.376795202067306,RAF1
Monoatomic Cation Homeostasis (GO:0055080),1/77,0.06710538575794313,0.09691921640998716,0,0,15.407120743034056,41.62219761611141,KCNA1
Organonitrogen Compound Catabolic Process (GO:1901565),1/78,0.06794823417091082,0.09691921640998716,0,0,15.206264323911382,40.88978353793229,BCKDK
Negative Regulation Of Protein Modification Process (GO:0031400),1/78,0.06794823417091082,0.09691921640998716,0,0,15.206264323911382,40.88978353793229,CDKN1A
Regulation Of TOR Signaling (GO:0032006),1/78,0.06794823417091082,0.09691921640998716,0,0,15.206264323911382,40.88978353793229,RPS6KA1
Negative Regulation Of Apoptotic Process (GO:0043066),2/482,0.06878137054718025,0.09691921640998716,0,0,5.078645833333334,13.594632662415698,RPS6KA1;RAF1
Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0000079),1/79,0.0687903633714564,0.09691921640998716,0,0,15.0105580693816,40.178634862671224,CDKN1A
Cellular Response To UV (GO:0034644),1/79,0.0687903633714564,0.09691921640998716,0,0,15.0105580693816,40.178634862671224,CDKN1A
Negative Regulation Of Cellular Component Organization (GO:0051129),1/79,0.0687903633714564,0.09691921640998716,0,0,15.0105580693816,40.178634862671224,RAF1
Calcium Ion Transmembrane Transport (GO:0070588),1/80,0.06963177394208621,0.096927429327384,0,0,14.819806403574088,39.48788238772356,CACNA1C
Regulation Of Cytokinesis (GO:0032465),1/80,0.06963177394208621,0.096927429327384,0,0,14.819806403574088,39.48788238772356,AURKA
Wound Healing (GO:0042060),1/80,0.06963177394208621,0.096927429327384,0,0,14.819806403574088,39.48788238772356,RAF1
Positive Regulation Of Growth (GO:0045927),1/81,0.07047246645026504,0.0973191203360803,0,0,14.633823529411766,38.81670264132201,RPS6KA1
Activation Of Protein Kinase Activity (GO:0032147),1/81,0.07047246645026504,0.0973191203360803,0,0,14.633823529411766,38.81670264132201,ADRB2
Regulation Of Phosphorylation (GO:0042325),1/82,0.0713124414727928,0.09808984044479008,0,0,14.452432824981845,38.16431494463284,CDKN1A
Calcium Ion Transmembrane Import Into Cytosol (GO:0097553),1/83,0.07215169959177546,0.09846584885465828,0,0,14.275466284074604,37.52997870137401,CACNA1C
Regulation Of Cell Division (GO:0051302),1/83,0.07215169959177546,0.09846584885465828,0,0,14.275466284074604,37.52997870137401,AURKA
Calcium-Mediated Signaling (GO:0019722),1/85,0.07382806741395515,0.09919755776083548,0,0,13.934173669467787,36.31268374332498,CACNA1C
Mitotic Spindle Organization (GO:0007052),1/85,0.07382806741395515,0.09919755776083548,0,0,13.934173669467787,36.31268374332498,AURKA
Integrin-Mediated Signaling Pathway (GO:0007229),1/85,0.07382806741395515,0.09919755776083548,0,0,13.934173669467787,36.31268374332498,PLEK
Negative Regulation Of Cell Cycle (GO:0045786),1/85,0.07382806741395515,0.09919755776083548,0,0,13.934173669467787,36.31268374332498,CDKN1A
Negative Regulation Of Protein Kinase Activity (GO:0006469),1/88,0.07633725672986817,0.10217448208459276,0,0,13.451656524678835,34.60565311468726,CDKN1A
Positive Regulation Of Peptidyl-Serine Phosphorylation (GO:0033138),1/89,0.07717222548711895,0.10289630064949191,0,0,13.29812834224599,34.06602362525984,RAF1
Positive Regulation Of Binding (GO:0051099),1/91,0.07884002491200945,0.10471881171518813,0,0,13.001307189542484,33.02766894797317,ADD2
B Cell Activation (GO:0042113),1/92,0.07967285673748564,0.10502331115395834,0,0,12.857789269553976,32.527973699604026,PRKCB
Positive Regulation Of Neuron Projection Development (GO:0010976),1/92,0.07967285673748564,0.10502331115395834,0,0,12.857789269553976,32.527973699604026,STMN2
Positive Regulation Of Cellular Component Biogenesis (GO:0044089),1/93,0.08050497738089572,0.10532230123515682,0,0,12.717391304347826,32.040656856642045,PLEK
Regulation Of Peptidyl-Serine Phosphorylation (GO:0033135),1/93,0.08050497738089572,0.10532230123515682,0,0,12.717391304347826,32.040656856642045,RAF1
Negative Regulation Of Cellular Process (GO:0048523),2/537,0.08296400902502893,0.10813286569554333,0,0,4.543691588785046,11.310831347709888,CDKN1A;RAF1
Negative Regulation Of Macromolecule Biosynthetic Process (GO:0010558),1/98,0.08465493309372914,0.1091108026541398,0,0,12.058823529411764,29.775308154544383,CDKN1A
Positive Regulation Of Protein-Containing Complex Assembly (GO:0031334),1/98,0.08465493309372914,0.1091108026541398,0,0,12.058823529411764,29.775308154544383,PLEK
Positive Regulation Of Cold-Induced Thermogenesis (GO:0120162),1/98,0.08465493309372914,0.1091108026541398,0,0,12.058823529411764,29.775308154544383,ADRB2
Hemopoiesis (GO:0030097),1/101,0.0871364089944587,0.11189472446520894,0,0,11.69529411764706,28.539797811620943,PLEK
Inorganic Cation Import Across Plasma Membrane (GO:0098659),1/103,0.08878719509547235,0.11359538196038374,0,0,11.46482122260669,27.76221178459644,CACNA1C
Positive Regulation Of Kinase Activity (GO:0033674),1/104,0.08961153050884178,0.11381318473385744,0,0,11.352941176470589,27.38637392725137,CDKN1A
Positive Regulation Of Vasculature Development (GO:1904018),1/104,0.08961153050884178,0.11381318473385744,0,0,11.352941176470589,27.38637392725137,PRKCB
Intrinsic Apoptotic Signaling Pathway (GO:0097193),1/105,0.0904351615790966,0.11444158628918404,0,0,11.243212669683258,27.0188131977752,CDKN1A
Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045),1/106,0.0912580888842393,0.11464915137803348,0,0,11.135574229691876,26.659273431080635,CDKN1A
Positive Regulation Of Cell Growth (GO:0030307),1/106,0.0912580888842393,0.11464915137803348,0,0,11.135574229691876,26.659273431080635,RPS6KA1
Positive Regulation Of Metabolic Process (GO:0009893),1/108,0.0929018344244166,0.11629438266078047,0,0,10.926333150082463,25.96328271398022,ADRB2
Adenylate Cyclase-Activating G Protein-Coupled Receptor Signaling Pathway (GO:0007189),1/110,0.0945427716606664,0.11792431734018605,0,0,10.724770642201834,25.296548009342803,ADRB2
Mitotic Sister Chromatid Segregation (GO:0000070),1/111,0.0953621885731626,0.11852157722664496,0,0,10.62673796791444,24.97361130786349,KIF2C
Calcium Ion Transport (GO:0006816),1/112,0.09618090509764518,0.1186913296949664,0,0,10.530471648118708,24.65735665214607,CACNA1C
Small GTPase Mediated Signal Transduction (GO:0007264),1/112,0.09618090509764518,0.1186913296949664,0,0,10.530471648118708,24.65735665214607,CDKN1A
Positive Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071902),1/117,0.10026400165930716,0.12311993171181115,0,0,10.074036511156187,23.16976571809541,ADRB2
Positive Regulation Of Cell Cycle Process (GO:0090068),1/118,0.1010785276838921,0.12311993171181115,0,0,9.987430869783813,22.889768968042276,AURKA
Positive Regulation Of Cell Projection Organization (GO:0031346),1/118,0.1010785276838921,0.12311993171181115,0,0,9.987430869783813,22.889768968042276,STMN2
Regulation Of Protein Kinase Activity (GO:0045859),1/119,0.10189235727874028,0.12311993171181115,0,0,9.902293120638086,22.615236719842347,CDKN1A
Regulation Of Protein-Containing Complex Assembly (GO:0043254),1/119,0.10189235727874028,0.12311993171181115,0,0,9.902293120638086,22.615236719842347,RAF1
Positive Regulation Of Angiogenesis (GO:0045766),1/119,0.10189235727874028,0.12311993171181115,0,0,9.902293120638086,22.615236719842347,PRKCB
Receptor-Mediated Endocytosis (GO:0006898),1/122,0.1043296729179585,0.12562881029567322,0,0,9.655323286339328,21.82295649315513,ADRB2
Regulation Of Cell Motility (GO:2000145),1/123,0.10514072229826572,0.12616886675791886,0,0,9.57569913211186,21.568837265640855,RAF1
Negative Regulation Of Growth (GO:0045926),1/124,0.10595107803152952,0.1262704628594941,0,0,9.49736967957915,21.31948479946905,CDKN1A
Neuron Projection Guidance (GO:0097485),1/124,0.10595107803152952,0.1262704628594941,0,0,9.49736967957915,21.31948479946905,VASP
Regulation Of Mitotic Cell Cycle (GO:0007346),1/125,0.10676074066511164,0.1263698562974791,0,0,9.420303605313093,21.074773673487663,AURKA
Negative Regulation Of Cell Growth (GO:0030308),1/125,0.10676074066511164,0.1263698562974791,0,0,9.420303605313093,21.074773673487663,CDKN1A
Cellular Response To Starvation (GO:0009267),1/126,0.10756971077056704,0.1268957944005333,0,0,9.344470588235296,20.83458271705315,CDKN1A
Antigen Receptor-Mediated Signaling Pathway (GO:0050851),1/134,0.11401660706245108,0.1340465515463952,0,0,8.778858911985846,19.06251225929767,PRKCB
Cellular Response To Metal Ion (GO:0071248),1/135,0.11481936936728154,0.13453582673338038,0,0,8.712906057945567,18.858171061974925,KCNA1
Ras Protein Signal Transduction (GO:0007265),1/144,0.12201338230456224,0.14200888642805234,0,0,8.160839160839162,17.167341601168975,CDKN1A
Actin Filament Organization (GO:0007015),1/144,0.12201338230456224,0.14200888642805234,0,0,8.160839160839162,17.167341601168975,MARCKS
Regulation Of Cold-Induced Thermogenesis (GO:0120161),1/146,0.12360453553638448,0.14338126122220596,0,0,8.047464503042596,16.82457683434384,ADRB2
Negative Regulation Of Protein Phosphorylation (GO:0001933),1/149,0.12598615986692616,0.14517610474731887,0,0,7.883147853736089,16.33059681765117,CDKN1A
Axon Guidance (GO:0007411),1/149,0.12598615986692616,0.14517610474731887,0,0,7.883147853736089,16.33059681765117,VASP
Neuron Development (GO:0048666),1/150,0.12677867536057502,0.14560719150323467,0,0,7.82984603237268,16.171078308333918,STMN2
Positive Regulation Of NF-kappaB Transcription Factor Activity (GO:0051092),1/152,0.12836167074753793,0.14694033361889208,0,0,7.725360342812622,15.859418874897433,PRKCB
Regulation Of Cellular Component Organization (GO:0051128),1/153,0.1291521517198897,0.1473604878640053,0,0,7.674148606811145,15.70717185844932,AURKA
Cellular Response To Growth Factor Stimulus (GO:0071363),1/155,0.1307310829477655,0.1485435367293612,0,0,7.573720397249809,15.409588975790411,STMN2
Regulation Of Apoptotic Process (GO:0042981),2/705,0.13104271774687898,0.1485435367293612,0,0,3.4279871977240397,6.9664650020494365,RPS6KA1;RAF1
Protein Autophosphorylation (GO:0046777),1/162,0.1362360770038511,0.15392907401733827,0,0,7.241870661308002,14.435699026304276,AURKA
Adenylate Cyclase-Modulating G Protein-Coupled Receptor Signaling Pathway (GO:0007188),1/163,0.13701981164116683,0.15431357427548886,0,0,7.19680464778504,14.304583045111348,ADRB2
Regulation Of Neuron Projection Development (GO:0010975),1/174,0.14559668293998512,0.1634440182681123,0,0,6.735464127847671,12.97866635801621,STMN2
Positive Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043123),1/175,0.14637239348820374,0.1637864724562537,0,0,6.696416497633536,12.867842408171857,PRKCB
Regulation Of Cell Population Proliferation (GO:0042127),2/766,0.14989006003133093,0.16718506695802296,0,0,3.1443062827225132,5.967431698742526,CDKN1A;RAF1
Phosphate-Containing Compound Metabolic Process (GO:0006796),1/184,0.15332392001745537,0.17046876730375227,0,0,6.364191578270653,11.934147775031484,BCKDK
Negative Regulation Of Macromolecule Metabolic Process (GO:0010605),1/186,0.15486142607713563,0.17162986074790826,0,0,6.294753577106518,11.741129142703194,AURKA
Axonogenesis (GO:0007409),1/188,0.15639629495093366,0.17278066870769815,0,0,6.22680088078012,11.552970612023575,VASP
Endocytosis (GO:0006897),1/189,0.15716274179723502,0.17307795615644872,0,0,6.193366708385482,11.46066058904648,ADRB2
Neuron Projection Development (GO:0031175),1/192,0.15945813830373404,0.17505183637129162,0,0,6.095164767477672,11.190563106127478,STMN2
Regulation Of Programmed Cell Death (GO:0043067),1/195,0.1617476299130038,0.17700684028215508,0,0,6,10.93030799092462,RAF1
Regulation Of Translation (GO:0006417),1/202,0.16706689368968466,0.1822547931160196,0,0,5.788996195493123,10.358603938884777,RPS6KA1
Regulation Of Angiogenesis (GO:0045765),1/205,0.16933680536594956,0.18415377583547013,0,0,5.702998846597462,10.127759560628936,PRKCB
Positive Regulation Of Protein Modification Process (GO:0031401),1/225,0.1843209055323322,0.19982453310047227,0,0,5.188550420168068,8.77423822004505,CDKN1A
Cilium Organization (GO:0044782),1/228,0.18654637973464205,0.2009849540175091,0,0,5.119201865768334,8.5955258483212,AURKA
Apoptotic Process (GO:0006915),1/228,0.18654637973464205,0.2009849540175091,0,0,5.119201865768334,8.5955258483212,RAF1
Positive Regulation Of Phosphorylation (GO:0042327),1/231,0.1887661184717403,0.20274879391409145,0,0,5.051662404092071,8.42236645544418,CDKN1A
Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043122),1/232,0.1895047592338975,0.2029158652719887,0,0,5.029539088362617,8.36583928133549,PRKCB
Positive Regulation Of DNA-binding Transcription Factor Activity (GO:0051091),1/246,0.1997792661980576,0.2132613025672517,0,0,4.738775510204082,7.631997892552949,PRKCB
Cellular Component Assembly (GO:0022607),1/260,0.20993067426728831,0.22341246068812337,0,0,4.479445832387009,6.992316061950365,ADD2
Regulation Of Protein Phosphorylation (GO:0001932),1/265,0.21352660943140056,0.22654652464063232,0,0,4.39349376114082,6.783527214270131,CDKN1A
Positive Regulation Of Signal Transduction (GO:0009967),1/266,0.21424393910560827,0.22661668938830296,0,0,4.37669256381798,6.742907678758303,PRKCB
Central Nervous System Development (GO:0007417),1/283,0.2263444052627623,0.2379693445058649,0,0,4.1093032957863995,6.105181726167229,MARCKS
Positive Regulation Of Cell Differentiation (GO:0045597),1/283,0.2263444052627623,0.2379693445058649,0,0,4.1093032957863995,6.105181726167229,RPS6KA1
Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169),1/284,0.2270506882292785,0.23799289007165336,0,0,4.094574932446477,6.070543052629082,ADRB2
Regulation Of Intracellular Signal Transduction (GO:1902531),1/297,0.2361771283788428,0.24680381963433504,0,0,3.9121621621621623,5.64592763145937,AURKA
Regulation Of Cell Cycle (GO:0051726),1/298,0.23687493033870088,0.24680381963433504,0,0,3.8987918399683106,5.6151296693355315,CDKN1A
Protein Transport (GO:0015031),1/313,0.24726998076706155,0.2568655322595147,0,0,3.708521870286576,5.181823041095028,PRKCB
Negative Regulation Of Gene Expression (GO:0010629),1/336,0.2629496856992922,0.2723407459028384,0,0,3.449868305531168,4.6083084646153685,AURKA
DNA Damage Response (GO:0006974),1/384,0.2946844455171831,0.304303225637922,0,0,3.010136691752419,3.677936032656272,CDKN1A
Positive Regulation Of Multicellular Organismal Process (GO:0051240),1/387,0.29662439162934084,0.3054002612041734,0,0,2.9862846693081377,3.62919776036838,ADRB2
Vesicle-Mediated Transport (GO:0016192),1/411,0.3119635485923433,0.32024576669656485,0,0,2.8080344332855094,3.2709920641116614,ADRB2
Nervous System Development (GO:0007399),1/433,0.32574641753069733,0.33341103911965486,0,0,2.662037037037037,2.985836735502773,MARCKS
Positive Regulation Of Cell Population Proliferation (GO:0008284),1/483,0.3561076019979903,0.36341772872522177,0,0,2.379790090309983,2.4571864351258017,CDKN1A
Positive Regulation Of Nucleic Acid-Templated Transcription (GO:1903508),1/557,0.3986819566019863,0.4056763768932493,0,0,2.0552264071096062,1.8899682848587889,RPS6KA1
Positive Regulation Of Cellular Process (GO:0048522),1/594,0.4189583580278499,0.42506562272213344,0,0,1.9233210990973115,1.6732580987476582,RPS6KA1
Regulation Of DNA-templated Transcription (GO:0006355),2/1922,0.5273619415421426,0.5334940571414698,0,0,1.1759114583333334,0.7524283130223667,PRKCB;RPS6KA1
Regulation Of Transcription By RNA Polymerase II (GO:0006357),2/2028,0.5577116252542589,0.5625612915608176,0,0,1.107847976307996,0.6468871132469569,PRKCB;RPS6KA1
Positive Regulation Of Transcription By RNA Polymerase II (GO:0045944),1/938,0.5789539139362094,0.5823004683520256,0,0,1.1956180551195932,0.6534440057960654,RPS6KA1
Regulation Of Gene Expression (GO:0010468),1/1127,0.6481160217115483,0.6499837912265671,0,0,0.9850590324939924,0.42720587105321106,AURKA
Positive Regulation Of DNA-templated Transcription (GO:0045893),1/1243,0.6850933865547655,0.6850933865547655,0,0,0.8875627545704272,0.3356763396427768,RPS6KA1
